SynAct Pharma AB. (8F8.F) Q4 2024 Earnings

30OctConfirmed
Q2 2024
Q3 2024
Q4 2024
-0.06
-0.05
-0.03
-0.02

Details

Expected EPS
-0.0187806937752
Actual EPS
N/A
Surprise EPS
0.02
Surprise Percent
+100%

Description

SynAct Pharma AB. (8F8.F) will report earnings of for Q4 2024 on October 30, 2024.

0 Comments

Share your thoughts